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SUMMARY
Invasive amoebiasis caused by Entamoeba histolytica is a
major global health problem. Virulence is a rare outcome of
infection, occurring in fewer than 1 in 10 infections. Not all
strains of the parasite are equally virulent, and understand-
ing the mechanisms and causes of virulence is an important
goal of Entamoeba research. The sequencing of the genome
of E. histolytica and the related avirulent species Entamoeba
dispar has allowed whole-genome-scale analyses of genetic
divergence and differential gene expression to be undertaken.
These studies have helped elucidate mechanisms of virulence
and identified genes differentially expressed in virulent and
avirulent parasites. Here, we review the current status of the
E. histolytica and E. dispar genomes and the findings of a
number of genome-scale studies comparing parasites of differ-
ent virulence.
Keywords differential gene expression, Entamoeba, genome,
virulence
INTRODUCTION
Amoebiasis is a disease of global importance, caused by
the eukaryotic parasite Entamoeba histolytica. It is the
most common worldwide cause of mortality from a proto-
zoon after malaria, killing an estimated 40 000–110 000
people annually, and causing 34–50 million cases of severe
disease. However, fewer than 10% of those infected develop
invasive amoebiasis (1). Those most at risk are people liv-
ing in areas of poor sanitation, as the parasite is transmit-
ted via a faecal–oral route. In such environments, exposure
may be very high. For example, acquisition of Entamoeba-
specific antibodies indicated an annual incidence of infec-
tion of 40% in children living in a slum in Bangladesh (2).
In Hu , Vietnam prevalence of Amoebic Liver Abscesses
(ALA) was higher in a more densely populated area than
in the city as a whole (3,4). In more affluent countries,
where poor living conditions are less common, amoebiasis
tends to be seen in certain groups, such as travellers return-
ing from endemic areas (5), men who have sex with men
and institutionalised individuals (6–9). Heterosexual and
female homosexual activity can also transmit amoebiasis
(10). Overall, men are more susceptible to invasive amoebi-
asis than women, despite similar infection rates (11). It is
hypothesised that, in pathogenic E. histolytica infections,
resistance to invasion is determined by a relatively small
number of host genes (12).
The molecular biology of Entamoeba is complex, and
much remains unknown, including chromosome number,
ploidy and whether they undergo sexual reproduction. In
an effort to better understand the biology of E. histolytica,
its genome was sequenced along with that of the related
species Entamoeba dispar. Since the first assembly and
annotation of the E. histolytica genome in 2005 (13,14),
significant advances have been made in understanding
host–parasite interactions and virulence in Entamoeba.I n
this review, we describe the current status of genome
annotation in virulent and nonvirulent Entamoeba species
and review some of the important genes identified by
genomic, proteomic and transcriptomic studies in the con-
text of the pathogenic E. histolytica life cycle.
Entamoeba histolytica’s pathogenic life cycle
Entamoeba histolytica has a two-stage life cycle, existing as
resistant infective cysts in the environment and potentially
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90   2011 Blackwell Publishing Ltdpathogenic trophozoites in the human colon. Upon excy-
station, trophozoites follow one of two paths. The more
common path is commensal colonisation, where trophozoites
inhabit the gut lumen and feed on enteric bacteria by
phagocytosis, a process involving rearrangement of the
amoebic cytoskeleton to internalise bacteria in lytic phago-
somes (15). The less common path leads to invasive amoe-
biasis. Virulence factors allow the parasite to cause
pathogenic amoebiasis via a variety of mechanisms, cru-
cially including those that allow it to resist and subvert the
host’s innate and adaptive immune responses (Figure 1).
Upon activation, previously commensal trophozoites
degrade the colonic mucosal layer then bind to host epithe-
lial cells (16,17). As reviewed by Lejeune et al. (18), the
bound trophozoites trigger pathology in the host tissues,
promoting penetration and infection. Apoptosis is induced
in the trophozoite-bound epithelial cells as a result of cas-
cading secretory proinflammatory cytokines. This cellular
damage and the subsequent lateral invasion through the
submucosa result in tissue inflammation and characteristic
flask-shaped ulcers (19). The importance of apoptosis in
amoebic virulence (20) is highlighted by studies on the lep-
tin signalling pathway. Leptin signalling has multiple roles
in the human body including regulation of the immune
response to infection (towards a Th1 inflammatory
response) and preventing apoptosis; however, experiments
in mice show that it is leptin’s anti-apoptotic role in gut
epithelia, rather than its role in immune effector cells,
which mediates susceptibility (21). An amino acid substitu-
tion (glutamine to arginine) in the leptin receptor is associ-
ated with increased susceptibility to, and severity of,
infection in both mice and humans (22).
In many respects, the immune response to E. histolytica
infection resembles that raised against the intestinal para-
sites Cryptosporidium and Giardia (23,24), with important
roles for reactive oxygen species (ROS), nitric oxide (NO)
and secreted IgA (25,26). Host immunity and pathology are
closely linked. Human immune cells are recruited to the site
of trophozoite invasion and, whilst attacking trophozoites,
enhance the pathology caused by the invasion. NO and
ROS released by immune effector cells damage E. histolytica
trophozoites; however, the parasites have evolved means to
minimise damage caused by these oxygen species, including
the expression of various surface molecules (27–31) and
internalisation and destruction of host immune cells (as well
as other host cells) by phagocytosis (15).
Entamoeba histolytica also faces challenges from adap-
tive immunity. Adaptive immunity appears to protect
against symptomatic disease, although not reinfection
(32,33). The occurrence of subsequent infections indicates
that immunity is either incomplete, ineffective against
heterologous parasite strains or that the parasite utilises
effective immune evasion strategies. For example, immuno-
globulins binding to surface proteins may block adhesion
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Figure 1 Key virulence factors of Entamoeba histolytica involved in pathogenic infections that have been identified by genome-scale investi-
gations. 1 = Binding to epithelial extracellular matrix via Gal⁄GalNac lectin and EhSTIRP; and degradation of MUC2 polymers via
secreted cysteine proteases. 2 = Subversion of host immune response, following binding of LPPG to host Toll-Like receptors 2 and 4, via
degradation of reactive oxygen species by superoxide dismutase, NADPH:flavin oxidoreductase and peroxiredoxin. Fe-hydrogenase inhibits
immune response by unknown mechanism. 3 = ‘Capping and Shedding’ of trophozoite surface antigens by host antibodies and lectins,
involving cytoskeletal rearrangement to translocate antigen–antibody complexes to ‘uroid’ of cell for shedding. Putative function for
EhROM1 in translocation. 4 = Direct contact between trophozoite and host or bacterial cell, leading to secretion of amoebapore-A, which
forms pores in target cell membrane without need for receptor.
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appear to be able to evade this arm of immunity by a pro-
cess of ‘capping and shedding’ where bound antibodies
are moved to the rear of the trophozoite, forming an
‘uroid’, and are shed. The host immune system is tempo-
rarily ‘blind’ to the parasite until different surface recep-
tors are bound, at which point the process begins again
(34,35).
Trophozoites that penetrate and cross the intestinal epi-
thelium can be disseminated to other organs, most com-
monly the liver, where they form abscesses. Entering the
relatively oxygen-rich environment of the bloodstream
exposes the trophozoites to greater oxidative stress. In
addition, greater exposure to humoral immunity and the
complement system places the trophozoites at greater risk
of inhibition and degradation. Consequently, it is likely
that trophozoites require different molecular pathways to
cause ALA, rather than remain as intestinal infections
(36,37).
In support of this theory, virulent E. histolytica troph-
ozoites exposed to conditions inducing heat shock demon-
strate differential gene expression. According to a
microarray analysis of 1131 transcripts, 471 genes were
downregulated and 40 upregulated when cells grown at
37 C were incubated at 42 C for 4 h. It has been hypoth-
esised that the large number of downregulated genes is
indicative of a general molecular reaction to a heat shock-
induced homeostatic imbalance (38).
After entering the hepatic sinusoids, pathogenic troph-
ozoites invade the parenchyma. The hepatocytes and
trophozoites are physically separated by a barrier of poly-
morphonuclear leukocyte (PMNs) and mononuclear host
cells. The trophozoites make direct contact with the
PMNs, resulting in lysis of the immune cells and the
release of their own lytic enzymes, which damage sur-
rounding hepatocytes. As surviving trophozoites reproduce
and spread, the necrotic regions coalesce into abscesses.
Immune epithelioid cells segregate these regions from
healthy tissue, forming granulomas, in which the trophozo-
ites are trapped with the expanding necrotic zones (37,39).
Differential virulence between Entamoeba species and
strains
Evidently, not all E. histolytica strains are equally virulent.
The genomic reference strain, E. histolytica HM-1:IMSS,
is the best-studied virulent strain of E. histolytica, derived
from a colonic biopsy taken from a man with dysentery in
Mexico in 1967 (13,40). The E. histolytica Rahman strain
was isolated from the stool of an Indian sailor in the UK
in 1964 (41) and is considered to be avirulent. It has
reduced ability to phagocytose erythrocytes, damage colo-
nic epithelia and cause ALA, relative to HM-1:IMSS
(29,42). A close human-infective relative of E. histolytica is
E. dispar, which is morphologically indistinguishable from
E. histolytica by microscopic analysis. Only in 1993 was it
described as a distinct species, under the name ‘dispar’
originally used by Brumpt in 1925 (43). E. dispar is aviru-
lent. Tracking E. dispar (strain SAW1734) cells on human
colonic explants shows that they do not break down the
mucus barrier or cause epithelial cell damage, unlike
E. histolytica HM-1:IMSS (Figure 2) (44). Recently, how-
ever, E. dispar has been associated both with cases of
amoebic colitis and ALA, and its avirulence status has
been questioned (45).
The genomes of Entamoeba histolytica and Entamoeba
dispar
The draft assembly and annotation of the E. histolytica
HM-1:IMSS genome was published in 2005 (13,14). A
reassembly of the genome, including more sequence data
and new annotation, was published in 2010 (46). The gen-
ome assembly and annotation was held on the Pathema
website (http://pathema.jcvi.org/Pathema/) (47). More
recently, the data have been made available on AmoebaDB
(http://www.amoebadb.org), part of the EuPathDB web
resource (48–50), along with the as-yet unpublished gen-
ome sequence of E. dispar. The E. histolytica genome
assembly represents approximately 20 Mb of sequence,
covered to >12.5 · depth (13,46). It remains fragmentary,
comprising 1496 scaffolds, most likely due to the high
number of repetitive elements in the genome (51). The
E. dispar assembly is slightly larger than that of E. histoly-
tica (22 Mb), but is sequenced to lower coverage depth
(4.5·) and is more fragmentary (3312 scaffolds). A total
of 8745 genes are predicted, slightly more than the 8300
for E. histolytica. Average divergence between orthologous
genes of the two species is approximately 38% at synony-
mous sites (Weedall G., unpublished observations).
The reassembly and reannotation of the E. histolytica
genome reduced the estimated number of genes from
10 000 to 8333, largely because of the removal of appar-
ently artefactual paralogues, very short gene models and
truncated genes (46). The majority of genes (55%)
encode unknown proteins (Figure 3). This can be com-
pared to other gut parasites, the apicomplexan Cryptospo-
ridium parvum (40% of 4367 genes are annotated as
hypothetical) and the diplomonad Giardia lamblia (75% of
9747 genes are annotated as hypothetical in isolate WB
from assemblage A) (data from EuPathDB). The predomi-
nance of uncharacterised genes presents a problem for
genome-wide analyses because the majority of genes of
interest are often of unknown function. The facility to
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(47,49), and such ‘community annotation’ has been
encouraged (52). Researchers can post corrections to gene
models, links to validating data and functional annota-
tions that can be incorporated into future annotations.
Annotation of hypothetical proteins in other species, such
as Plasmodium falciparum, has been improved by using
annotated genes with similar transcriptional profiles, anno-
tated orthologues and automated literature mining (53).
Similar methods may aid the annotation of E. histolytica.
Genome-scale analyses of Entamoeba virulence
Entamoeba genome sequences are used either as a means
to identify sequences generated by processes such as mass
spectrometry of peptides (29,54,55) or sequencing of
cDNA from differential display PCR (36,56), or to design
microarrays for hybridisation-based analyses (57–61).
Many genes involved in amoebic pathogenesis have been
identified by genome-wide analyses. Investigations have
compared gene expression in the same strain in different
environments, identifying genes that may be important for
(a) (b) (c)
(d) (e)
(f) (g)
Figure 2 Comparison of colonisation of the colonic surface by Entamoeba histolytica and Entamoeba dispar. Panels show breakdown of
mucus by E. histolytica after 0 h (a) and 2 h (b). Enlargement of region shows aggregates of trophozoites and recruited human cells (c).
After 4 h, trophozoites begin to damage (d) and to penetrate epithelia (e). Conversely, after 4 h, E. dispar binds to, but does not degrade,
the mucus barrier (f) and, as shown by manually removing the mucus layer, does not recruit immune cells to the epithelial surface (g). [Rep-
rinted, with permission, from (44)].
Figure 3 Comparison of the current status of the Entamoeba
histolytica and Entamoeba dispar genome annotations, indicating
the relative proportions of genes with putative functions. ‘Anno-
tated’ = Percentage of non-hypothetical genes in the annotation;
‘GO’ = Percentage of genes associated with a ‘Gene Ontology’
term, i.e. those with either a cellular component, molecular
function or biological process; ‘EC’ = Percentage of genes with
‘Enzyme Commission’ numbers, i.e. enzymes identified as being
involved in known chemical reactions. Based upon figures
from AmoebaDB (48–50). Based on most recent genome
annotation (46).
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lines that show different virulence characteristics
(29,57,58,60,62).
A DNA microarray created from a clone library repre-
senting 2110 unique genes has been used to compare
diversity of genomic DNA among E. histolytica and
E. dispar strains (63) and transcriptional differences
between E. histolytica HM-1:IMSS, E. histolytica Rahman
and E. dispar SAW760 (60). A 70-bp oligonucleotide
DNA microarray representing 6242 unique E. histolytica
HM-1:IMSS genes has been used to compare transcrip-
tional differences between HM-1:IMSS and Rahman and
to compare syngenic cell lines of differential virulence
derived from HM-1:IMSS (57,58). A different microarray
using 25-bp oligonucleotide probes representing 9435
E. histolytica HM-1:IMSS open reading frames has been
used to compare E. histolytica trophozoites from murine
intestinal infections and from in vitro culture (59) and to
compare the transcriptional responses of HM-1:IMSS and
Rahman to oxidative and nitrosative stress (61).
The numbers of putative differentially expressed genes
among strains vary with the different methods and criteria
used to define differential expression. However, broad
trends are apparent. A greater proportion of E. dispar
genes than Rahman genes appear to be downregulated rel-
ative to HM-1:IMSS (58,60). A number of genes are
downregulated in both avirulent cell lines. For instance, of
32 genes with lower mRNA expression in Rahman, 29
also showed lower expression in E. dispar (60). The follow-
ing sections describe some of the genes identified by these
studies as potentially important virulence factors.
Genes involved in survival and virulence in the intestine
Experimental infections of mouse intestines induced differ-
ential expression (twofold or greater) of 523 genes: 326 on
day 1 post-infection, 109 on day 29 post-infection and 88
at both time points (59). The authors speculated that an
initial stress response associated with adaptation to the
new environment might partly explain the large number of
genes differentially regulated early in infection. Among
putative virulence factors showing differential expression
were cysteine proteases and members of the galactose- and
N-acetyl-D-galactosamine-binding lectin (Gal⁄GalNAc–lec-
tin) complex on the parasite surface (16).
An important process in amoebic virulence is the degra-
dation of the mucus layer, which enables the trophozoites
to reach the gut epithelial layer (Figure 2). Trophozoites
release cysteine proteases to degrade the main component
of the mucus barrier, MUC2. Different members of the
cysteine protease gene family are expressed in culture and
in mouse intestine, suggesting that different gene family
members may play unique roles important in different
environments (59). Cysteine protease expression is lower
overall in E. dispar than in E. histolytica (64), indicating
their role in virulence, and CP-A5 (gene ID, EHI_168240),
a key protease for the degradation of the MUC2 polymer
(17,65,66), is a pseudogene in E. dispar (67). However,
CP-A5 showed no statistically significant differential
expression between E. histolytica HM-1:IMSS and
Rahman. CP-A4 (EHI_050570), CP-A6 (EHI_151440) and
CP-B1 (EHI_117650) were expressed to a greater degree in
HM-1:IMSS, whereas CP-A3 (EHI_159610), CP-A7
(EHI_039610) and CP-B9 (EHI_181230) were greater in
Rahman (58). Numerous cysteine protease genes (e.g.
EHI_127470, EHI_019390, EHI_144040 and EHI_132640)
are pseudogenes in the E. histolytica genome, and this,
along with their divergence from E. dispar orthologues
(64), suggests a degree of evolutionary plasticity in this
gene family.
Trophozoites bind to the mucus layer and to epithelial
cells via the Gal⁄GalNAc–lectin complex (16). Two genes
encoding light subunits in the Gal⁄GalNAc lectin – lgl2
(EHI_049690) and lgl3 (EHI_027800) – were downregulat-
ed to different degrees during the course of intestinal
infection (59). The importance of the downregulation of
lgl3 in invasive infection was supported by transcriptional
analysis showing 22-fold higher expression in the nonviru-
lent Rahman strain, compared with HM-1:IMSS (58).
Other molecules involved in binding to host cells include
the E. histolytica serine-, threonine- and isoleucine-rich
proteins (EhSTIRP) (68). These proteins are encoded by a
small gene family in E. histolytica (EHI_012330,
EHI_004340 and EHI_025700).
Surviving host responses to invasive amoebiasis
Nitric oxide and ROS released by neutrophils, macrophag-
es, monocytes and dendritic cells constitute a major threat
to the trophozoites, which they can counteract by the
actions of a number of molecules expressed on their sur-
faces: peroxiredoxin, superoxide dismutase (SOD) and
NADPH:flavin oxidoreductase (27–29,31). SOD generates
H2O2 in the presence of O2
), NADPH:flavin oxidoreduc-
tase catalyses the reduction of O2 to H2O2, and peroxire-
doxin reduces the H2O2 from both pathways to H2O (69).
Fe-hydrogenase, which, in bacteria, is involved in survival
of oxidative stress (30), is also expressed by the trophozo-
ites (58). Large numbers of genes show differential regula-
tion in response to oxidative and nitrosative stress, and
there is a substantial overlap in the genes involved in these
responses. HM-1:IMSS shows a more robust response to
stress than Rahman, with more genes differentially regu-
lated overall and to a greater degree (61).
Peroxiredoxin is more highly expressed in E. histolytica
HM-1:IMSS than in Rahman according to analyses of
I. W. Wilson et al. Parasite Immunology
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is downregulated in E. dispar relative to E. histolytica
HM-1:IMSS (28,60). In E. histolytica HM-1:IMSS, perox-
iredoxin is expressed on the surface where it is co-localised
with the Gal⁄GalNAc lectin, possibly to degrade ROS
released from bound immune cells (28). In contrast,
expression in E. dispar is restricted to the cytoplasm,
suggesting an inability of E. dispar to survive the oxidative
burst that would be inflicted upon it following host inva-
sion. E. histolytica peroxiredoxin sequences are highly
divergent from their E. dispar orthologues (63). The cur-
rent E. histolytica genome annotation contains a number
of putative peroxiredoxin genes (EHI_001420, EHI_061980,
EHI_114010, EHI_122310, EHI_123390, EHI_201250,
EHI_145840, EHI_018740, EHI_183180 and EHI_084260)
and pseudogenes (EHI_121620, EHI_139570 and
EHI_172720). Whether all of these genes are real, func-
tional and expressed remains to be determined. If so, it is
possible that gene copy number variations between strains
and species of Entamoeba affect overall gene expression
levels.
Involvement of other putative oxidative stress response
genes in virulence is less clear. Fe-hydrogenase
(EHI_073390) is more highly expressed in E. histolytica
HM-1:IMSS than in E. dispar, suggesting a role in viru-
lence, yet within E. histolytica, it is more highly expressed
in Rahman than HM-1:IMSS (58,60). SOD (EHI_159160)
is also more highly expressed in E. histolytica Rahman
than in HM-1:IMSS (29). SOD does appear to play a role
in oxidative stress resistance: increased expression of SOD
and peroxiredoxin is associated with metronidazole resis-
tance, implying an involvement in detoxification of nitro-
gen-based free radicals generated by metronidazole
activation (70,71).
Immunoglobulins binding to amoebic surface proteins
can disrupt trophozoite cell functions, block adhesion to
host receptors and activate the complement pathway. The
parasite can avoid these outcomes by cysteine protease-
mediated clipping of bound antibodies and complement
(72,73) and by shedding the bound antibodies from its
surface. Binding of host antibodies to amoebic surface
antigens induces actin- and myosin-mediated redistribution
to a membranous posterior appendage of the cell, the
‘uroid’, where this ‘cap’ is shed mostly as membrane-
bound vesicles (34,35,74). A rhomboid protease involved
in shedding surface proteins, EhROM1 (EHI_197460), was
identified by searching the E. histolytica genome sequence
for motifs conserved across known rhomboid proteases
(75). EhROM1 specifically cleaves the heavy chain subunit
of the Gal⁄GalNAc lectin and localises to the uroid (75).
However, EhROM1 knock-down mutants showed no sig-
nificant change in cap formation or complement resis-
tance, but did show reduced ability to adhere to host cells
and reduced phagocytic ability (76), suggesting a novel
role for this protein (75,76). Proteomic analysis of uroid-
extruded vesicles identified several surface-linked proteins,
in addition to the Gal⁄GalNAc lectin, that are apparently
capped and discarded, implying that they are involved in
host–amoeba interactions. These included calreticulin, a
multifunctional antigen with a notable involvement in cal-
cium signalling, and the variable surface antigen M17
(77).
A number of proteins with uncertain functions show dif-
ferential expression between E. histolytica HM-1:IMSS and
the noninvasive Rahman and E. dispar (29,59). Grainin-1
was upregulated in E. histolytica Rahman, and grainin-2
was upregulated in both nonvirulent cell lines. The
sequences of both grainins contain at least one metal-ligat-
ing EH-hand motif, commonly seen in proteins that bind
calcium. Both genes are upregulated in culture in response
to inducers of programmed cell death (PCD), and a stress-
response role diminishing intracellular Ca
2+ was suggested
(78), as was a role in calcium-dependent endocytosis and
granular exocytosis, aiding pathology (79). Lower levels of
expression of both genes in mouse intestines, and of grainin
1 in ALA samples, were seen relative to in vitro cultures,
possibly owing to higher stress levels in in vitro conditions
(36,59). In the current genome assembly, seven putative
grainin genes are annotated: grainin 1 (EHI_167300) is rel-
atively divergent from its nearest paralogues (EHI_120360,
71% amino acid identity; EHI_060380, 57% identity); grai-
nin 2 (EHI_167310) has a shorter, near-identical, paralogue
(EHI_111720); both are relatively divergent from their
nearest paralogues (EHI_164430, EHI_164440, both 56%
amino acid identity).
A LIM domain-containing protein (EHI_096420) was
more highly expressed in E. histolytica HM-1:IMSS than
in Rahman or E. dispar (29,54). Its function is not known,
but it has been shown to localise to the plasma membrane
and to bind to the actin cytoskeleton via its LIM domain
(80). Alcohol dehydrogenase 3 (ADH3) was more highly
expressed in HM-1:IMSS relative to Rahman and E. dis-
par (29,54). ADH3 (EHI_125950 and EHI_198760) is
expressed at greater levels on the cell surface of
HM-1:IMSS than E. dispar and, when overexpressed in
HM-1:IMSS and Rahman cells, increased host inflamma-
tory response, although no definite role in virulence was
determined (54). ADH2 (EHI_024240, EHI_150490 and
EHI_160940) was more highly expressed in HM-1:IMSS
than in E. dispar (54). ADH2 is associated with the cell
membrane and is involved in iron scavenging from the
host’s transferrin (81).
Trophozoites can phagocytose host epithelial cells, ery-
throcytes and immune cells. Phagocytosis is modulated by
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ments, to restructure the amoebic cytoskeleton as neces-
sary (82). Proteomic analysis, by liquid chromatography
and tandem mass spectroscopy (LC-MS⁄MS), of phago-
some proteins allows identification of proteins differen-
tially expressed over time and in different conditions. In
wild-type E. histolytica HM-1:IMSS and a strain overex-
pressing myosin IB (MyoIB+), approximately 1000 pro-
teins were identified overall. Of these, about 150 proteins
present in the early phagosome were associated with the
cytoskeleton (including actin, coactosin and talin), were
signalling molecules (including PI3-K and Ras GAP) or
were involved in intracellular trafficking (including calreti-
culin). Of those associated with the cytoskeleton, seven
proteins were functionally linked to myosin IB, demonstra-
ble by their expression in detectable levels in MyoIB+ only
(83). Also in HM-1:IMSS, of 159 phagosomal proteins
detected, 51 were constitutively expressed, whilst the
remaining 108 showed differential expression across the
monitored 2-h period. Those constitutively expressed
included CP-A5, actin and the Gal⁄GalNAc lectin. The
more numerous transient proteins included many Rab
GTPases and several of the Rac cytoskeletal proteins,
reflecting the necessary fluidity of the cytoskeleton in the
phagocytic process. The same study reported inter-strain
variation in expressed E. histolytica phagosome proteins,
suggesting a role in differential virulence (84).
Virulence factors involved in amoebic liver abscess
Death from amoebiasis results mainly from the formation
of abscesses on the liver after trophozoites escape the gut,
so understanding the molecular basis of abscess formation
is of considerable interest. Comparisons of the transcripto-
mes of E. histolytica trophozoites axenically cultured in vitro
with those isolated from liver abscesses using differential
display PCR (DD-PCR) identified small numbers of genes
differentially expressed between the two (36,56). Among
these were genes encoding grainin-1, a flavoprotein, a
GTP-binding protein and ribosomal proteins (36,56).
A cell line derived from HM-1:IMSS (‘HM1A’), which
has lost the ability to cause ALA, has been compared to
virulent HM-1:IMSS (‘HM1B’) at both proteomic and
transcriptomic levels (57,62). Eighty-seven genes showed
twofold or greater differential (mRNA) expression between
HM1A (47 genes upregulated) and HM1B (40 genes
upregulated) (57). Thirty-one proteins showed 2.3-fold or
greater differential protein expression between HM1A (21
upregulated) and HM1B (10 upregulated) (62). Only two
genes, Fe-hydrogenase-2 (EHI_005060) and a C2-domain-
containing protein (EHI_069320), were found differentially
expressed (upregulated in HM1A) at both the proteomic
and the transcriptomic levels. Despite using the same
microarray, little overlap was seen in the transcripts down-
regulated in HM-1:IMSS clone A and in Rahman, relative
to HM-1:IMSS clone B (57,58). Only 1 gene was signifi-
cantly downregulated in both Rahman and avirulent
HM-1:IMSS, and of the 152 transcripts upregulated in
E. histolytica HM-1:IMSS relative to Rahman, only five
were also significantly upregulated in the pathogenic
HM-1:IMSS clone B relative to clone A. Two of these five
genes encoded AIG1-like proteins. AIG1 proteins are
small GTPases originally identified in Arabidopsis thaliana
(85) where they confer resistance to bacterial infections.
AIG1-like proteins are encoded by a large gene family in
E. histolytica (57,59) and may be involved in bacterial
interactions. This lack of overlap suggests that the nature
of avirulence in Rahman and HM-1:IMSS clone A may be
quite different.
Another investigation comparing virulent and avirulent
lines derived from the E. histolytica HM-1:IMSS strain
compared mRNA expression in 1130 genes and showed
downregulation (>twofold, P<0.05) of 21 genes and upreg-
ulation of 29 genes in the virulent line (86). Among the
upregulated genes in the virulent line were the surface
antigen ariel-1, which has been shown to be absent from
E. dispar (87), and several lysine-rich proteins (‘KRiPs’)
and lysine- and glutamic acid-rich proteins (‘KERPs’).
Gene knock-down of KERP1 using antisense RNA
reduced the formation of liver abscesses (86).
None of these studies identified the virulence factor
amoebapore-A (AP-A; EHI_159480). The amoebapore’s
role in pathogenesis has been demonstrated in hamster
and severe combined immunodeficient (SCID) mouse liv-
ers (88,89). AP-A appeared to be essential for ALA for-
mation in hamsters, but suppression in the mouse model
did not completely prevent ALA, suggesting that other
processes are important in ALA formation. AP-A is
inserted into host plasma membranes, without the need to
bind to a host receptor, upon direct contact between a tro-
phozoite and a host cell (90), forming pores and lysing the
host cell (91). Amoebapores also have a bacteriolytic func-
tion, being able to lyse gram-positive bacteria (88,90).
Characterising candidate virulence factors
Characterisation of gene function has proven difficult in
Entamoeba as gene knock-outs have not been achieved.
There has, however, been some success with transcriptional
gene silencing and, more recently, with RNAi-mediated
gene knock-down (92–94). The gene encoding AP-A has
been silenced in some, although not all, cell lines, using
what was originally designed to be a putative overexpres-
sion vector. The mechanism of silencing is not known for
certain, although involvement of a short interspersed
I. W. Wilson et al. Parasite Immunology
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have been proposed (95,96). The ‘G3’ E. histolytica cells
this silencing mutation gave rise to are virulence attenu-
ated, being impaired in their ability to digest phagocytosed
cells (although not impaired in their ability to phagocytose
them in the first instance) and unable to cause ALA
(88,97). Cell lines that have been silenced for AP-A expres-
sion continued to show AP-A silencing even when selec-
tion for the vector was removed, although in other cases,
silencing has not been integrated permanently into the cell
lineage and future generations have reverted to their wild
type (98). Moreover, additional silencing of genes could be
achieved in this line using a vector with an additional gene
in it. By this method, CP-A5 and Ehlgl were silenced
(99,100). Gene silencing affected multiple members of the
gene families containing the target gene (99), and, interest-
ingly, downregulation of several lgl genes led to upregula-
tion of others, a possible compensatory mechanism.
Silencing of EhLIM-A – the gene encoding a LIM-like
protein – has been achieved in a similar fashion (80).
RNAi-mediated gene knock-down has been achieved using
different methods of administering the siRNA: bacterial
expression of double-stranded RNA followed by either
adding the bacteria to Entamoeba culture or extracting the
dsRNA and soaking Entamoeba trophozoites in them (94),
or addition of vectors expressing short hairpin RNA
(sense and antisense linked by a loop) to the trophozoites
(92). Beta-tubulin, KERP1, URE3-BP, IGl and EhC2A
have been ‘knocked down’ by these methods. Continued
improvement of molecular tools for targeted gene silencing
will help to characterise the roles of specific genes and
gene families in host–parasite interactions.
Concluding Remarks
The genome-scale studies made possible by sequencing of
the E. histolytica genome have greatly improved our
knowledge of the pathogenesis of E. histolytica and identi-
fied many genes that may play important roles in host–
parasite interactions. Comparisons of different strains of
E. histolytica and of the related species E. dispar show dif-
ferences in sequence and in expression that may account
for different virulence profiles. In order for further gen-
ome-scale studies into genetic and gene expression differ-
ences to be successful in the future improved gene
annotation is vital. It is hoped that a model of ‘commu-
nity annotation’ may help rapidly improve and disseminate
information characterising Entamoeba genes. Much work
has yet to be done before we understand the complexities
of Entamoeba virulence. Continual improvement to the
assembly and annotation of Entamoeba genomes is central
to this effort.
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